Prospective Randomized Study Comparing FK 506 (Prograf) and Cyclosporine A (Neoral) as Primary Immunosuppression in Cadaveric Renal Transplants at a Single Institution: Interim Report of the First 80 Cases

By Morris-Stiff G.   Singh J.   Ostrowski K.   Balaji V.   Moore R.   Darby C.   Lord R.   Jurewicz W.A.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1295-1296

Elsevier

Access to resources Recommend Favorite

Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation

By Yu L.   Wang Y.   Fu S.J.   Cheng X.J.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1709-1710

Elsevier

Access to resources Recommend Favorite

Frequency of switch from cyclosporine to fk 506 before and after neoral use in pediatric liver transplantation

By Gridelli B.   Colledan M.   Lucianetti A.   Ulla L.   Riva S.   Segalin A.   Fassati L.R.   Torre G.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1861-1862

Elsevier

Access to resources Recommend Favorite

Neoral is superior to FK 506 in liver transplantation

By Levy G.A.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1812-1815

Elsevier

Access to resources Recommend Favorite

Tacrolimus (FK506) Is Superior to Cyclosporine in Liver Transplantation

By Busuttil R.W.   Holt C.D.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 534-538

Elsevier

Access to resources Recommend Favorite